Archives of Pharmacal Research

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Mechanism of Erectogenic Effect of the Selective Phosphodiesterase Type 5 Inhibitor, DA-8159

  • Doh, Hyoun-Mie (Research Laboratories, Dong-A Pharm. Co. Ltd.) ;
  • Shin, Chang-Yell (Research Laboratories, Dong-A Pharm. Co. Ltd.) ;
  • Son, Mi-Won (Research Laboratories, Dong-A Pharm. Co. Ltd.) ;
  • Ko, Jun-Il (Research Laboratories, Dong-A Pharm. Co. Ltd.) ;
  • Yoo, Moo-Hi (Research Laboratories, Dong-A Pharm. Co. Ltd.) ;
  • Kim, Soon-Hoe (Research Laboratories, Dong-A Pharm. Co. Ltd.) ;
  • Kim, Won-Bae (Research Laboratories, Dong-A Pharm. Co. Ltd.)
  • Published : 2002.12.01
Download PDF
⟨ Previous Next ⟩

Abstract

OA-8159, a new Phosphodiesterase (PDE) 5 inhibitor, has exhibited potent erectogenic potential in a penile erection test in rats and anesthetized dogs. In this study, we investigated the mechanism of its erectogenic activity by measuring the activity of OA-8159 against a various PDE isozymes and assessing cGMP and cAMP formation in a rabbit corpus cavernosum in vitro. DA-8159 inhibited the PDE 5 activity in rabbit and human platelets, which the $IC_{50}$ was 5.84$\pm$1.70 nM and 8.25$\pm$2.90 nM, respectively. The $IC_{50}$ of DA-8159 on PDE 1, PDE2, PDE 3 and PDE 6 were 870$\pm$57.4 nM, $101\pm$5 $\mu$M, 52.0$\pm$3.53 $\mu$M and 53.3$\pm$2.47 nM, respectively. This suggests that DA-8159 is a potent, highly selective, competitive inhibitor of PDE 5-catalyzed cGMP hydrolysis. The rates of cGMP hydrolysis catalyzed by human platelets-derived PDE 5 as a function of the cGMP concentration (5~100 nM) and two-fixed DA-8159 concentration (11.3 and 18.8 nM) were investigated in order to characterize the mode of PDE 5 inhibition by DA-8159. DA-8159 increased the apparent 4K_{m}$ value for cGMP hydrolysis but had no effect on the apparent $V_{max}$, indicating a competitive mode of inhibition. DA-8159 increased the cGMP concentrations in the rabbit corpus cavernosum dose dependently. In the presence of sodium nitroprusside (SNP), DA-8159 significantly sti\mulated the accu\mulation of cGMP when compared to the control level. This indicated that the enhancement of a penile erection by DA-8159 involved the relaxation of the cavernosal smooth \muscle by NO-sti\mulated cGMP accu\mulation. In conclusion, DA-8159 is a selective inhibitor of PDE 5-catalyzed cGMP hydrolysis and the enhancement of a penile erection by DA-8159 is mediated by the relaxation of the cavernosal smooth \muscle by the NO-sti\mulated cGMP accu\mulation.

Keywords

References

  1. Andersson, K-E. and Wagner, G., Physiology of penile erection. Physiol. Rev., 75, 191- 236 (1995) https://doi.org/10.1152/physrev.1995.75.1.191
  2. Artemyev, O. A., Arshavsky, V. Y. and Cote, R. H., Photoreceptor phosphodiesterase: interaction of inhibitory gamma subunit and cyclic GMP with specific binding sites on catalytic subunits. Methods, 14, 93-104 (1998) https://doi.org/10.1006/meth.1997.0568
  3. Azadzoi, K. M. and De Tajeda, I. S., Hypercholestroemia impairs endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle. J. Urol., 146, 238-240 (1991) https://doi.org/10.1016/S0022-5347(17)37759-5
  4. Ballard, S. T., Gingell, C. J.,Tang, K., Turner, L. A., Price, M. E. and Naylor A. M., Effects of Sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J. Urol., 159, 2164-2171 (1998) https://doi.org/10.1016/S0022-5347(01)63299-3
  5. Beavo, J. A., Cyclic nucleotide phophodiesterase: functional implications of multiple isoform. Physiol. Rev., 75, 725-748 (1995) https://doi.org/10.1152/physrev.1995.75.4.725
  6. Burentt, A. L., Role of nitric oxide in the physiology of erection. Biol. Reprod., 52, 485-489 (1995) https://doi.org/10.1095/biolreprod52.3.485
  7. Burnett, A L., Lowenstein, C. J., Bredt, D. S., Chang, T. S. K. and Snyder, S. H., Nitric oxide: a physiologic mediator of penile erection. Scinece, 257, 401-403 (1992) https://doi.org/10.1126/science.1378650
  8. Corbin, J. D. and Francis, S. H., Cyclic GMP phosphodiesterase-5: target of sildenafil. J. Biol. Chem., 274, 13729-13732 (1999) https://doi.org/10.1074/jbc.274.20.13729
  9. Corbin, J. D., Turko, I. V, Beasley, A and Francis, S. H., Phosphorylation of phosphodiesterase-5 by cyclic nucleotidedependent protein kinase alters its catalytic and allosteric cGMP-binding activities. Eur. J. Biochem., 267, 2760-2767 (2000) https://doi.org/10.1046/j.1432-1327.2000.01297.x
  10. De Tajeda, I. S., Goldstein I., Adazoi, K., Krane, R. J. and Cohen, R. A., Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N. Engl. J. Med., 320, 1025-1030 (1989) https://doi.org/10.1056/NEJM198904203201601
  11. Dishy, V., Sofowora, G., Harris, P. A., Kandcer, M., Zhan, F., Wood, A. J. and Stein, C. M., The effect of sildenafil on nitric oxide-mediated vasodilation in healthy men. Clin. Pharmacol. Ther., 70(3), 270-279 (2001) https://doi.org/10.1067/mcp.2001.117995
  12. Dousa, T. P., Cyclic-3',5'-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney. Kidney Int., 55, 2962 (1999)
  13. Ekholm, D., Belfrage, P., Manganiello, V. and Degerman, E., Protein kinase A-dependent activation of PDE4 (cAMP-specific nucleotide phosphodiesterase) in cultured bovine vascular smooth muscle cells. Biochim. Biophys. Acta, 1356, 6470 (1997)
  14. Finberg, J. P. M., Levy, S. and Vardi, Y, Inhibition of nerve stimulation-induced vasodilation in corpora cavernosa of the pithed rat by blockade of nitric oxide synthetase. Br. J. Pharmacol., 108, 1038-1042 (1993) https://doi.org/10.1111/j.1476-5381.1993.tb13502.x
  15. Fink, T. L., Francis, S. H., Beasley, A., Grimes, K. A and Corbin, J. Expression of an active, monomeric catalytic domain of the cGMP- binding cGMP-specific phosphodiesterase (PDE5). J. Biol. Chem., 274, 34613-34620 (1999) https://doi.org/10.1074/jbc.274.49.34613
  16. Freelish, M. and Noack, E., Correlation between nitric acid formation during degradation of organic nitrates and activation of guanylate cyclase. Eur. J. Pharmacol., 139, 19-30 (1987) https://doi.org/10.1016/0014-2999(87)90493-6
  17. Gillespie, P. G., and Beavo J. A, Inhibition and stimulation of photoreceptor by dipyridamol and M&B. Mol. Pharm., 36, 773-781 (1989)
  18. Hidaka, H. and Asano, T., Human blood platelet 3 ': 5'-cyclic nucleotide phosphodiesterase. Isolation of low-Km and high-Km phosphodiesterase. Biochim. Biophys. Acta, 429, 485-497 (1976) https://doi.org/10.1016/0005-2744(76)90296-5
  19. Hidaka, H. and Shibuya, M., A new assay of cyclic nucleotide phosphodiesterase; its application to human serum. Biochem. Med., 10, 301-311 (1974) https://doi.org/10.1016/0006-2944(74)90033-7
  20. Hurley, J. B. and Stryer, L., Purification and characterization of the gamma regulatory subunit of the cyclic GMP phosphodiesterase from retinal rod outer segments. J. Biol. Chemistry, 257, 11094-11099 (1982)
  21. Hurwitz, R L., Bunt-Milam, A. H., Chang, M. L. and Beavo, J. A, cGMP phosphodiesterase in rod and cone outer segments of the retina. J. Mol. Biol., 260, 568-573 (1985)
  22. Jeremy, J. Y., Ballard, S. A., Naylor, A. M., Miller, M. A. W. and Angelini, G. D., Effects of Sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic Amp levels in the rabbit corpus cavernosum in vitra. Br. J. Urol., 79, 958-963 (1997) https://doi.org/10.1046/j.1464-410X.1997.00206.x
  23. Lim, J., Pahlke, G. and Conti, M., Activation of the cAMPspecific phosphodiesterase PDE4D3 by phosphorylation: identification and function of an inhibitory domain. J. Biol. Chem., 274, 19677-19685 (1999) https://doi.org/10.1074/jbc.274.28.19677
  24. Lue, T. F, Hemodynamics of erection in the monkey. J. Urol., 130, 1237-1241(1983) https://doi.org/10.1016/S0022-5347(17)51768-1
  25. Trigo-Rocha, F, Hsu, G. L., Donatucci, C. F. and Lue, T. F., The role of cyclic adenosine monophosphate, cyclic guanosine monophosphate, endothelium and nonadrenergic, noncholinergic, neurotranasmission in canine penile erection. J. Urol., 149, 872-877 (1993) https://doi.org/10.1016/S0022-5347(17)36250-X
  26. Wang, J. H., Teo, T. S., Ho, H. C., and Stevens, F. S., Bovine heart protein activator of cyclic nucleotide phosphodiesterase. Adv. in Cyclic Nucleotide Res., 5., 179-194 (1975)